umbilical cord blood-derived immune cell therapy (IMMUNIQUE)

N/A

Report date: 2025/03/20 09:15:13

Base Information

Drug Nameumbilical cord blood-derived immune cell therapy (IMMUNIQUE)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedipost Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMedipost Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A